| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.NBD.2015.02.019 |
| P698 | PubMed publication ID | 25731749 |
| P50 | author | Bernard L. Schneider | Q37377455 |
| Elpida Tsika | Q56670281 | ||
| Julien Dusonchet | Q64856197 | ||
| Darren J Moore | Q87693446 | ||
| P2093 | author name string | Philippe Colin | |
| An Phu Tran Nguyen | |||
| P2860 | cites work | Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis | Q24306886 |
| LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing | Q24597817 | ||
| P921 | main subject | Parkinson's disease | Q11085 |
| pathology | Q7208 | ||
| striatum | Q1319792 | ||
| Adenoviridae | Q193447 | ||
| P304 | page(s) | 49-61 | |
| P577 | publication date | 2015-02-28 | |
| P1433 | published in | Neurobiology of Disease | Q15716606 |
| P1476 | title | Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease | |
| P478 | volume | 77 |
| Q57143848 | Animal models of neurodegenerative diseases |
| Q91741105 | CAV-2-Mediated GFP and LRRK2G2019S Expression in the Macaca fascicularis Brain |
| Q64866880 | Genetic Modifiers of Neurodegeneration in a Drosophila Model of Parkinson's Disease |
| Q51082143 | Interaction of LRRK2 and α-Synuclein in Parkinson's Disease |
| Q98177378 | LRRK2 and Protein Aggregation in Parkinson's Disease: Insights From Animal Models |
| Q97066874 | LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease? |
| Q28078899 | LRRK2 inhibitors and their potential in the treatment of Parkinson's disease: current perspectives |
| Q39137358 | Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation. |
| Q48239635 | Mechanisms of Mutant LRRK2 Neurodegeneration |
| Q39206443 | Models of LRRK2-Associated Parkinson's Disease |
| Q36379938 | Neurite Aggregation and Calcium Dysfunction in iPSC-Derived Sensory Neurons with Parkinson's Disease-Related LRRK2 G2019S Mutation. |
| Q48502440 | New developments in genetic rat models of Parkinson's disease |
| Q99716681 | Pathogenic LRRK2 requires secondary factors to induce cellular toxicity |
| Q39263032 | Targeting LRRK2 in Parkinson's disease: an update on recent developments |
| Q64864674 | The G2019S mutation in LRRK2 imparts resiliency to kinase inhibition |
| Q39206431 | Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity. |
Search more.